Company profile: Parexel
1.1 - Company Overview
Company description
- Provider of biopharmaceutical services, including clinical research, medical communications, consulting, commercialization, and advanced technology for pharmaceutical, biotechnology, and medical device industries. Offerings include clinical trial management, RWE and late phase research, market access strategy, regulatory compliance and pharmacovigilance, and advanced analytics.
Products and services
- Clinical Trial Management: Delivers end-to-end clinical trial management—develops protocols, accelerates patient recruitment, and executes trial operations—to advance new therapies for pharmaceutical, biotechnology, and medical device sponsors worldwide
- Regulatory Compliance and Pharmacovigilance: Supplies post-approval regulatory support—prepares submissions, delivers strategic consulting, and oversees pharmacovigilance—to maintain compliance and safety for biopharmaceutical products across global markets
- Real-World Evidence (RWE) and Late Phase Research: Offers late-stage real-world evidence programs—develops strategies to generate data via observational studies and conducts late-stage clinical trials—supporting therapeutic evaluation in real-world settings
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Parexel
Pyxa Solutions
HQ: United States
Website
- Description: Provider of consulting, operational, and strategic services supporting life sciences teams.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pyxa Solutions company profile →
Anagram
HQ: Spain
Website
- Description: Provider of clinical research organization (CRO) services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Anagram company profile →
BioSim
HQ: United States
Website
- Description: Provider of solutions to enable and accelerate drug discovery at quantum accuracy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioSim company profile →
AmbioPharm
HQ: United States
Website
- Description: Provider of peptide manufacturing and development services, including GMP and non-GMP custom peptide synthesis via solid phase, solution phase, or hybrid processes. Manufactures active pharmaceutical ingredients and generic peptides, develops research-grade complex peptides, and offers analytical development and validation for HPLC/UPLC, serving pre-clinical, medicinal, and toxicology programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AmbioPharm company profile →
Javara
HQ: United States
Website
- Description: Provider of integrated clinical research services to healthcare organizations, delivering turnkey, practice-based clinical trial infrastructure to expand access to clinical trials and change the clinical research experience for providers and patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Javara company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Parexel
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Parexel
2.2 - Growth funds investing in similar companies to Parexel
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Parexel
4.2 - Public trading comparable groups for Parexel
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →